Latest News
A listing of recent publications by Yale Cancer Center researchers and clinicians in the first quarter of 2024
- November 10, 2024
Cancers of the head and neck are relatively rare, accounting for less than 4% of cases in the United States, but they are extremely complicated to treat because they attack essential daily functions. A Smilow specialty team coordinates treatment from start to finish.
- July 24, 2024
Drs. Barbara Burtness and Maryam Lustberg named Fellows of the American Society of Clinical Oncology
Barbara Burtness, MD, Anthony N. Brady Professor of Medicine (Medical Oncology), Chief Translational Research Officer at Yale Cancer Center, and Chief of Head and Neck Cancers/Sarcoma, and Maryam Lustberg, MD, MPH, Associate Professor of Internal Medicine (Medical Oncology) and Chief of Breast Medical Oncology, have been named Fellows of the American Society of Clinical Oncology (FASCO).
- May 21, 2024
Dr. Barbara Burtness Receives Presidential Citation from AAO-HNS.
- April 29, 2024Source: ACS Journals
Dr. Barbara Burtness discusses how she has applied advances in molecular biology to better treat patients with head and neck cancers.
- April 17, 2024
Camille C. R. Ragin, PhD, MPH — a member of the collaborative SPORE research program for Head and Neck Cancer at Yale — was honored with a lectureship at this year's annual meeting of the American Association for Cancer Research (AACR).
- April 16, 2024
Curtis Pickering and the Yale Head and Neck SPORE organized the first symposium of the Yale-NY region on head and neck translational research at Yale West Campus on April 12, 2024.
- April 15, 2024
Reflecting the complexities of the disease, cancer research is an ever-evolving field requiring constant infusions of innovation and funding. Starting this year, those resources at Yale Cancer Center will be augmented by its Translational Incubator, an initiative to further support and accelerate cooperation and collaboration among Yale experts.
- March 18, 2024
On March 15, 2024, Dr. Barbara Burtness presented at the 75th Anniversary of the National Institute of Dental and Craniofacial Research (NIDCR).
- November 02, 2023Source: Fox Chase
YHN SPORE collaborators at FCCC have received a five-year, $13.3 million competitive grant renewal from the National Cancer Institute (NCI), part of the National Institutes of Health, to address cancer health disparities.